Our position on the leading issues affecting research and people with dementia and how these issues impact our work.
Our position on Brexit and the five things we need from government for dementia research to thrive.
Our position on the use of scientific evidence to support public policies aimed at dementia risk reduction.
Our position on the merits of a dementia diagnosis, measures to improve diagnosis rates and timely diagnoses, and population screening.
How to enable recruitment of people with and without dementia to take part in clinical trials and other research studies.
How health data can be shared safely and appropriately to benefit people with dementia and medical research.
Detailing the policies that govern our work with pharmaceutical and biotech companies.